Filing Flows › Solventum (SOLV) › Recalls, complaints & regulation
Solventum (SOLV): EPA violations and clinical trials
Solventum (SOLV) beyond its filings: 1 EPA-regulated facility in violation, no penalties in five years; 3 active clinical trials.
EPA facilities in violation
| Facility (as registered) | City | Status | Penalties |
|---|---|---|---|
| SOLVENTUM US LLC | Brookings, SD | Violation Identified | — |
Facilities in the EPA's ECHO register whose registered name matches the company's; a facility can belong to another business of the same name.
Solventum's latest quarter
Solventum, Q3 2026: revenue $1.9B (-7% year over year), operating margin 3.5%, net loss $12.0M, operating cash flow $177M. The chart follows the revenue to costs, profit and cash.
Questions
Has Solventum been fined by the EPA?
The 4 EPA-regulated facilities on file under its name drew no penalties in five years; 1 is in violation now.
How many clinical trials does Solventum have?
3 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.